🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
491 results for “Novo”
MedicineActive substanceLicence holderStatus
Edoxaban Krka 15 mg film-coated tablet
PA1347/115/001
Edoxaban tosylate monohydrate KRKA, d.d., Novo mesto Not marketed
Edoxaban Krka 30 mg film-coated tablet
PA1347/115/002
Edoxaban tosylate monohydrate KRKA, d.d., Novo mesto Not marketed
Edoxaban Krka 60 mg film-coated tablet
PA1347/115/003
Edoxaban tosylate monohydrate KRKA, d.d., Novo mesto Not marketed
Efavirenz/Emtricitabine/Tenofovir disoproxil Krka 600 mg/200 mg/245 mg film-coated tablets
EU/1/17/1263/001-002
Tenofovir disoproxil succinate, Efavirenz, Emtricitabine KRKA, d.d., Novo mesto
Eltrombopag Krka 25 mg film-coated tablets
PA1347/113/001
Eltrombopag KRKA, d.d., Novo mesto Marketed
Eltrombopag Krka 50 mg film-coated tablets
PA1347/113/002
Eltrombopag KRKA, d.d., Novo mesto Marketed
Eltrombopag Krka 75 mg film-coated tablets
PA1347/113/003
Eltrombopag KRKA, d.d., Novo mesto Not marketed
Empagliflozin/Metformin Krka 12.5 mg/1000 mg film-coated tablets
PA1347/122/004
Empagliflozin, Metformin Hydrochloride KRKA, d.d., Novo mesto Not marketed
Empagliflozin/Metformin Krka 12.5 mg/850 mg film-coated tablets
PA1347/122/003
Empagliflozin, Metformin Hydrochloride KRKA, d.d., Novo mesto Not marketed
Empagliflozin/Metformin Krka 5 mg/1000 mg film-coated tablets
PA1347/122/002
Empagliflozin, Metformin Hydrochloride KRKA, d.d., Novo mesto Not marketed
Empagliflozin/Metformin Krka 5 mg/850 mg film-coated tablets
PA1347/122/001
Empagliflozin, Metformin Hydrochloride KRKA, d.d., Novo mesto Not marketed
Emtricitabine/Tenofovir disoproxil Krka 200 mg/245 mg film-coated tablets
EU/1/16/1151/001-004
Emtricitabine, Tenofovir disoproxil KRKA, d.d., Novo mesto
Emtricitabine/Tenofovir disoproxil Krka d.d 200 mg/245 mg film-coated tablets
EU/1/17/1182/001-004
Tenofovir disoproxil, Emtricitabine KRKA, d.d., Novo mesto
Enalapril/Lercanidipine Krka 10 mg/10 mg film-coated tablets
PA1347/029/001
Enalapril maleate, Lercanidipine KRKA, d.d., Novo mesto Marketed
Enalapril/Lercanidipine Krka 20 mg/10 mg film-coated tablets
PA1347/029/002
Enalapril maleate, Lercanidipine KRKA, d.d., Novo mesto Marketed
Enyglid 0.5 mg tablets
EU/1/09/580/1-6
Repaglinide KRKA, d.d., Novo mesto
Enyglid 1 mg tablets
EU/1/09/580/7-12
Repaglinide KRKA, d.d., Novo mesto
Enyglid 2 mg tablets
EU/1/09/580/13-18
Repaglinide KRKA, d.d., Novo mesto
Eplerenone Krka 25 mg film-coated tablets
PA1347/078/001
Eplerenone KRKA, d.d., Novo mesto Marketed
Eplerenone Krka 50 mg film-coated tablets
PA1347/078/002
Eplerenone KRKA, d.d., Novo mesto Marketed
ESCADRA 20 mg hard gastro-resistant capsules
PA1347/123/001
Esomeprazole KRKA, d.d., Novo mesto Not marketed
ESCADRA 40 mg hard gastro-resistant capsules
PA1347/123/002
Esomeprazole KRKA, d.d., Novo mesto Not marketed
Escitalopram Krka 10 mg film-coated tablets
PA1347/046/002
Escitalopram oxalate KRKA, d.d., Novo mesto Marketed
Escitalopram Krka 15 mg film-coated tablets
PA1347/046/003
Escitalopram oxalate KRKA, d.d., Novo mesto Marketed
Escitalopram Krka 20 mg film-coated tablets
PA1347/046/004
Escitalopram oxalate KRKA, d.d., Novo mesto Marketed
Escitalopram Krka 5 mg film-coated tablets
PA1347/046/001
Escitalopram oxalate KRKA, d.d., Novo mesto Marketed
Esomeprazole Krka 20 mg hard gastro-resistant capsules
PA1347/017/001
Esomeprazole KRKA, d.d., Novo mesto Marketed
Esomeprazole Krka 40 mg hard gastro-resistant capsules
PA1347/017/002
Esomeprazole KRKA, d.d., Novo mesto Marketed
Esperoct 1000 IU Powder and solvent for solution for injection
EU/1/19/1374/002
TUROCTOCOG ALFA PEGOL Novo Nordisk A/S
Esperoct 1500 IU Powder and solvent for solution for injection
EU/1/19/1374/003
TUROCTOCOG ALFA PEGOL Novo Nordisk A/S
Esperoct 2000 IU Powder and solvent for solution for injection
EU/1/19/1374/004
TUROCTOCOG ALFA PEGOL Novo Nordisk A/S
Esperoct 3000 IU Powder and solvent for solution for injection
EU/1/19/1374/005
TUROCTOCOG ALFA PEGOL Novo Nordisk A/S
Esperoct 4000 IU Powder and solvent for solution for injection
EU/1/19/1374/006
TUROCTOCOG ALFA PEGOL Novo Nordisk A/S
Esperoct 500 IU Powder and solvent for solution for injection
EU/1/19/1374/001
TUROCTOCOG ALFA PEGOL Novo Nordisk A/S
Esperoct 5000 IU Powder and solvent for solution for injection
EU/1/19/1374/007
TUROCTOCOG ALFA PEGOL Novo Nordisk A/S
Estrofem 2 mg film-coated tablets
PA0218/050/001
Estradiol Novo Nordisk A/S Marketed
Etoricoxib Krka 120 mg film-coated tablets
PA1347/064/004
Etoricoxib KRKA, d.d., Novo mesto Marketed
Etoricoxib Krka 30 mg film-coated tablets
PA1347/064/001
Etoricoxib KRKA, d.d., Novo mesto Marketed
Etoricoxib Krka 60 mg film-coated tablets
PA1347/064/002
Etoricoxib KRKA, d.d., Novo mesto Marketed
Etoricoxib Krka 90 mg film-coated tablets
PA1347/064/003
Etoricoxib KRKA, d.d., Novo mesto Marketed
Ezetimibe Krka 10 mg tablets
PA1347/066/001
Ezetimibe KRKA, d.d., Novo mesto Marketed
Ezetimibe/Atorvastatin Krka 10 mg/10 mg film-coated tablets
PA1347/116/001
Ezetimibe, Atorvastatin calcium trihydrate KRKA, d.d., Novo mesto Marketed
Ezetimibe/Atorvastatin Krka 10 mg/20 mg film-coated tablets
PA1347/116/002
Ezetimibe, Atorvastatin calcium trihydrate KRKA, d.d., Novo mesto Marketed
Ezetimibe/Atorvastatin Krka 10 mg/40 mg film-coated tablets
PA1347/116/003
Ezetimibe, Atorvastatin calcium trihydrate KRKA, d.d., Novo mesto Marketed
Ezetimibe/Atorvastatin Krka 10 mg/80 mg film-coated tablets
PA1347/116/004
Ezetimibe, Atorvastatin calcium trihydrate KRKA, d.d., Novo mesto Marketed
Ezetimibe/Simvastatin Krka 10 mg/10 mg tablets
PA1347/067/001
Ezetimibe, Simvastatin KRKA, d.d., Novo mesto Not marketed
Ezetimibe/Simvastatin Krka 10 mg/20 mg tablets
PA1347/067/002
Ezetimibe, Simvastatin KRKA, d.d., Novo mesto Marketed
Ezetimibe/Simvastatin Krka 10 mg/40 mg tablets
PA1347/067/003
Ezetimibe, Simvastatin KRKA, d.d., Novo mesto Marketed
Febuxostat Krka 120 mg film-coated tablets
EU/1/18/1347/005-008
Febuxostat KRKA, d.d., Novo mesto
Febuxostat Krka 80 mg film-coated tablets
EU/1/18/1347/001-004
Febuxostat KRKA, d.d., Novo mesto
1 2 3 4 5 6

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.